Related Experiment Video

Updated: Feb 8, 2026

Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis
08:34

Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis

Published on: June 3, 2016

15.8K

MiR-532-5p alleviates hypoxia-induced cardiomyocyte apoptosis by targeting PDCD4

Jideng Ma1, Jinwei Zhang1, Yujie Wang1

  • 1Farm Animal Genetic Resource Exploration and Innovation Key Laboratory of Sichuan Province, Sichuan Agricultural University, Chengdu, Sichuan 611130, China.

Gene
|July 1, 2018
PubMed

Insights

MicroRNAs (miRNAs) protect heart cells from damage caused by low oxygen. This study shows miR-532-5p reduces apoptosis in hypoxia-exposed heart cells, offering a potential therapeutic target.

Area of Science:

  • Molecular Biology
  • Cardiology
  • Biochemistry

Background:

  • MicroRNAs (miRNAs) regulate gene expression post-transcriptionally.
  • Hypoxia, often caused by acute myocardial infarction, leads to cardiomyocyte damage and apoptosis.
  • Hypoxia alters miRNA expression in H9c2 cells, including miR-532-5p.

Purpose of the Study:

  • To investigate the role of miR-532-5p in the response of H9c2 cells to hypoxia.
  • To determine if miR-532-5p exhibits cardioprotective effects under hypoxic conditions.

Main Methods:

  • Quantitative analysis of miR-532-5p expression in hypoxia-exposed H9c2 cells and rat myocardium.
  • Assessment of H9c2 cell apoptosis following hypoxia.
  • Identification of the direct target of miR-532-5p using molecular biology techniques.

Main Results:

  • miR-532-5p expression was significantly down-regulated in hypoxia-exposed H9c2 cells and the myocardium of acute myocardial infarction rats.
  • Overexpression of miR-532-5p alleviated hypoxia-induced apoptosis in H9c2 cells.
  • Programmed cell death protein 4 (PDCD4) was identified as a direct target of miR-532-5p.

Conclusions:

  • miR-532-5p plays a crucial role in protecting cardiomyocytes against hypoxia-induced apoptosis.
  • The anti-apoptotic mechanism of miR-532-5p involves the regulation of PDCD4.
  • miR-532-5p represents a potential therapeutic agent for conditions involving myocardial infarction and hypoxia.
Keywords:
Acute myocardial infarctionApoptosisH9c2 cellsHypoxiamiRNA

More Related Videos

Induction and Characterization of Pulmonary Hypertension in Mice using the Hypoxia/SU5416 Model07:10

Induction and Characterization of Pulmonary Hypertension in Mice using the Hypoxia/SU5416 Model

Published on: June 3, 2020

10.8K
Synthesis of an In vivo MRI-detectable Apoptosis Probe06:58

Synthesis of an In vivo MRI-detectable Apoptosis Probe

Published on: July 31, 2012

9.6K

Related Concept Videos

Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
15.2K
Hypoxia01:23

Hypoxia

Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
2.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.9K
Induced-fit Model01:13

Induced-fit Model

Most chemical reactions in cells require enzymes—biological catalysts that speed up the reaction without being consumed or permanently changed. They reduce the activation energy needed to convert the reactants into products. Enzymes are proteins, that usually work by binding to a substrate—a reactant molecule that they act upon.
Enzymes exhibit substrate specificity, meaning that they can only bind to certain substrates. This is mainly determined by the shape and chemical...
89.4K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.5K
Target Cell Response to Hormones01:22

Target Cell Response to Hormones

Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
5.8K